Results of univariate and multivariate logistic regression in our study indicate, that expression of CD38 on CD8+ cells alone or together with expression of PD-1 on CD4+ cells could be used as a biomarker of survival in hospitalized patients with COVID-19. The gene discussed is CD8A; the disease is COVID-19.